NCT00001440View on ClinicalTrials.gov

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 1995

Study Completion Date

January 31, 2002

Conditions
Breast NeoplasmNeoplasm Metastasis
Interventions
PROCEDURE

Autologous T cells

DRUG

Interleukin-2

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH